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Background
Maternal fish oil supplementation during pregnancy has
been associated with altered infant immune responses and
a reduced risk of clinical allergy. The objective of this
study was to examine the effect of early postnatal fish oil
supplementation on infant cellular immune function at six
months of age and infant allergic diseases.
Methods
In a double-blind randomized controlled trial (ACTR
N12606000281594), 420 infants of high atopic risk
received fish oil (containing 280mg docosahexaenoic acid
(DHA) and 110mg eicosapentanoic acid (EPA)) or con-
trol oil daily from birth to six months. Fatty acid levels,
induced cytokine responses, were assessed at 6 months of
age in 150 infants. Eczema, food allergy, asthma and sen-
sitization were assessed in 323 infants who completed
clinical follow up at 12 months of age.
Results
DHA and EPA levels were significantly higher in the fish
oil group and erythrocyte arachidonic acid (AA) levels
were lower (all p<0.05). Infants in the fish oil group had
significantly lower IL-13 responses (p=0.036) to house
dust mite and higher IFNg (p=0.035) and TNF (p=0.017)
responses to phytohaemaglutinin. Infants with relatively
high DHA levels had lower Th2 responses to allergens
including lower IL-13 (p=0.020) and IL-5 (p=0.045) to
b-lactoglobulin. Although n-3 PUFA levels at 6 months
were associated with lower risk of eczema (p=0.033) and
recurrent wheeze (p=0.027), the association with eczema
was not significant after multiple comparisons. Between
group comparisons revealed no differences in the occur-
rence of allergic outcomes.
Conclusions
Postnatal fish oil supplementation increased infant n-3
polyunsaturated fatty acid (PUFA) levels and associated
with lowered allergen-specific Th2 responses and ele-
vated polyclonal Th1 responses. However, postnatal fish
oil supplementation did not prevent childhood allergic
disease.
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